Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013
Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013
复制标题
DOI：
10.1016/j.vaccine.2014.03.054
复制
发表时间：
2014-05-07
期刊：
影响因子：
5.5
通讯作者：
Castilla, Jesus
中科院分区：
文献类型：
--
作者：
Guevara, Marcela;Ezpeleta, Carmen;Castilla, Jesus
肺炎球菌结合疫苗（PCVs）于2001年（PCV7）、2009年（PCV10）和2010年（PCV13）在西班牙获准用于儿童，并可用于私人购买。本研究评估了西班牙纳瓦拉地区在使用PCV7（2004-2009）和PCV13（2010-2013）期间侵袭性肺炎球菌病（IPD）发病率和分离血清型模式的变化。儿童的百分比
Pneumococcal conjugate vaccines (PCVs) were licensed for use in children and became available for private purchase in Spain in 2001 (PCV7), 2009 (PCV10) and 2010 (PCV13). This study evaluates changes in the incidence of invasive pneumococcal disease (IPD) and the pattern of serotypes isolated in Navarre, Spain, between the period of use of PCV7 (2004-2009) and that of PCV13 (2010-2013). The percentage of children